Prudential Financial Inc Harmony Biosciences Holdings, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 31,261 shares of HRMY stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,261

Previous 34,071 8.25%

Holding current value

$1.09 Million

Previous $1.03 Million 21.52%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$30.0 - $39.95 $84,300 - $112,259	-2,810 Reduced 8.25%	31,261 $1.25 Million
Q2 2024 Aug 13, 2024	SELL	$28.81 - $33.01 $86,430 - $99,030	-3,000 Reduced 8.09%	34,071 $1.03 Million
Q1 2024 May 14, 2024	SELL	$29.93 - $35.06 $13,169 - $15,426	-440 Reduced 1.17%	37,071 $1.24 Million
Q4 2023 Feb 13, 2024	SELL	$19.2 - $33.78 $561,235 - $987,423	-29,231 Reduced 43.8%	37,511 $1.21 Million
Q3 2023 Nov 13, 2023	SELL	$31.89 - $39.03 $94,011 - $115,060	-2,948 Reduced 4.23%	66,742 $2.19 Million
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $396,835 - $486,611	13,011 Added 22.96%	69,690 $2.45 Million
Q1 2023 May 12, 2023	SELL	$30.8 - $53.92 $361,746 - $633,290	-11,745 Reduced 17.17%	56,679 $1.85 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $15,753 - $21,135	347 Added 0.51%	68,424 $0
Q3 2022 Nov 04, 2022	BUY	$42.06 - $55.45 $230,909 - $304,420	5,490 Added 8.77%	68,077 $3.02 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $928,387 - $1.44 Million	-27,680 Reduced 30.66%	62,587 $3.05 Million
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $2.19 Million - $3.38 Million	66,112 Added 273.7%	90,267 $4.39 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $823,443 - $1.06 Million	24,155 New	24,155 $1.03 Million

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.05B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Harmony Biosciences Holdings, Inc. Transaction History